SEC Form 4 · accession 0001093557-15-000132
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Terrance H Gregg
Officer — Executive Chairman · Director
Period of report
Apr 30, 2015
Accepted (ET)
May 4, 2015 · 7:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 4, 2015 | M | 20,000 | $8.95 | A | 450,626 | D | |
| Common StockF1,F2 | May 4, 2015 | S | 20,000 | $68.0638 | D | 430,626 | D | |
| Common StockF3,F4 | Apr 30, 2015 | S | 14,250 | $67.13 | D | 522,139 | I | by Trust |
| Common Stock | holding | — | — | — | 11,461 | I | by IRA |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $8.95 | May 4, 2015 | M | 20,000 | D | Jan 2, 2009 | Jan 2, 2018 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $68.02 to $68.13. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- F2Included in this number are 207,658 unvested restricted stock units, 35,000 of which were granted on March 8, 2015 and will vest on March 8, 2016, 116,798 unvested restricted stock units granted on March 8, 2014, 5,078 of which shall vest each month through March 8, 2017, and 55,860 unvested restricted stock units granted on March 11, 2013, 5,078 of which shall vest each month through March 11, 2016.
- F3The reporting person contributed Dexcom, Inc. Common Stock to an exchange fund, pursuant to an agreement dated March 5, 2015 to contribute shares of DexCom, Inc. Common Stock in exchange for shares of the exchange fund. The Dexcom, Inc. Common Stock was valued at $67.13 per share for the purposes of determining the number of shares of the exchange fund issuable to the reporting person with respect to the April 30, 2015 closing of the exchange fund.
- F4Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.